Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Search

Total 51 results found. Search for [ Torrent Pharmaceuticals ]

Results 1 to 21 of 51
PTI
November 12, 2018



PTI
November 4, 2018



PTI
January 25, 2018



PTI
January 8, 2018



PTI
December 11, 2017



E. kumar sharma
New Delhi, December 11, 2017
Indian pharma companies are facing strong headwinds, but they are also exploring every new opportunity to ensure a quick recovery.


PB Jayakumar
November 6, 2017
There was a time when the company was staring at bankruptcy and also there was a time it was contemplating huge acquisitions for growth with private equity support.


Mail Today Bureau
November 4, 2017
Unichem's business under consideration comprises a portfolio of over 120 products, manufacturing plant at Sikkim catering to these two markets and all the employees engaged in it, Torrent Pharmaceuticals said in a filing to the BSE.


Mail Today Bureau
November 4, 2017
Unichem's business under consideration comprises a portfolio of over 120 products, manufacturing plant at Sikkim catering to these two markets and all the employees engaged in it, Torrent Pharmaceuticals said in a filing to the BSE.


PTI
New Delhi, November 3, 2017
Unichem's business under consideration comprises a portfolio of over 120 products, manufacturing plant at Sikkim catering to these two markets and all the employees engaged in it.


Goutam Das
New Delhi, June 1, 2017
As automation spreads, millions of jobs could be on the block. What's the way out?


By Team BT
Delhi, December 26, 2016
The fourth edition of BT MindRush was a spectacular success, brainstorming challenges before corporate India, felicitating the best CEOs, and much, much more.


by P.B. Jayakumar
Delhi, December 12, 2016
Torrent Pharmaceuticals was a late entrant to the US, but Samir Mehta has led it to fast-paced growth in that market.


Avneet Kaur
November 17, 2016
Out of BSE 500 companies, 291 companies-- excluding BFSI and Oil & Gas companies -- showed clear signs of improvement in bottom line in the second quarter of FY17. Net profit for this group showed a healthy growth of 9 per cent over the corresponding quarter last year. The y-o-y percentage growth in the same period last year was 2.61 per cent.


Avneet Kaur
June 22, 2016
The drugs and pharmaceuticals industry saw an improvement in the number of projects completed in 2015/16. A total of 26 projects were commissioned during the year.


By E. Kumar Sharma
Delhi, April 25, 2016
In the third quarter, Dr. Reddy's revenues from India rose 34 per cent from the corresponding quarter of the previous year (partly due to acquisition of a few established brands of Belgian company UCB in India). However, in March, the growth was 7 per cent.


E Kumar Sharma
December 18, 2015
Till end of November, over 170 inspections were held in India as against over 70 inspection and certainly much less than 100 conducted five years ago by the US regulator in India.


BT Online
New Delhi, October 30, 2015
Shares of ITC fell over 5 per cent in trade on Friday after the cigarette-FMCG-to-hotel major reported its September quarter results below Street estimates.


Joe C Mathew
October 1, 2015
The US Patent and Trademark Office's trial and appeal board quashed Novartis's patent claims stating they were obvious (and hence not inventions that merit patent protection).


PTI
New Delhi, August 27, 2015
In a statement, drug pricing regulator National Pharmaceutical Pricing Authority (NPPA) said, \"It has fixed/revised the prices in respect of 39 formulation packs ... and one corrigendum ... related to the ceiling price fixation of Paclitaxel injection.\"


PAGES 1 OF 3  123